Bioanalysis Zone

Interview with Dr Michael Zhou (BASi) on new technologies and the need for harmonised guidelines


Michael ZhouMichael Zhou spoke to Bioanalysis Zone in June 2011, following his appointment as Senior Director of Global R&D at BASi (Bioanalytical Systems Inc).

Could you tell Bioanalysis Zone a little about your career to date and how you ended up in your current role?

I have been engaged in the bioanalytical world for more than 20 years (involved with both pharmaceutical sponsors and CROs). I obtained my PhD as a part-time student under the supervision of Dr Donald L. Sparks at the University of Delaware (DE, USA) while I was working for DuPont. My early careers were with big Pharma companies, such as Purdue Pharma LP, Johnson & Johnson and Cardinal Health, Inc. Later, I worked at a couple of mid-/small-size pharmaceutical, biotechnology and development companies. Most recently, I joined BASi (Bioanalytical Systems Inc.) as a Senior Director of Global R&D. I love to be part of a CRO business, far more dynamic than the Pharma sector. My expertise has been with LC–MS/MS along with ligand-binding assays (LBAs) for a range of different therapeutic indications. I have always had a great passion for analytical and bioanalytical chemistry.

To view restricted content, please:

Leave A Comment